A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases - Zozaya, Néboa (Universidad de Las Palmas de Gran Canaria) ; Arrizubieta Basterrechea, M.I. (Hospital de Galdakao (Usansolo, Biscaia)) ; Bollo, E. (Complejo Asistencial Universitario de León) ; Castellvi, Ivan (Institut d'Investigació Biomèdica Sant Pau) ; Espín, J. (Andalusian School of Public Health) ; Ortego, N. (Hospital Universitario San Cecilio (Granada)) ; Poveda-Andrés, J.L. (Hospital Universitari i Politècnic La Fe (València)) ; Rodríguez Portal, J.A. (Centro de Investigación Biomédica en Red - Enfermedades Respiratorias (CIBERES)) ; Rivero, A. (Bioregión de Salud y Bienestar (BioMad)) ; Marcos-Rodríguez, J.A. (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Verde, L. (Integrated Health Area) ; Universitat Autònoma de Barcelona
 
Comments (0) | Reviews (0)
Start a discussion about any aspect of this document.

 Subscribe to this discussion. You will then receive all new comments by email.

Add comment


Once logged in, authorized users can also attach files.
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>